EyePoint Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.03.25	EyePoint Pharmaceuticals, Inc. Q4 Loss Increases, Misses Estimates (RTTNews)
05.02.25	EyePoint Pharmaceuticals Stock Gains 3% After Positive Phase 2 Trial Results (RTTNews)
05.02.25	EyePoint Announces Positive 6-Month Data From Duravyu Trial For Diabetic Macular Edema (RTTNews)
30.01.25	Keep An Eye On EYPT - Diabetic Macular Edema, Wet AMD Trial Results Awaited (RTTNews)
30.10.24	EyePoint Pharma Prices Public Offering Of About 12.73 Mln Shares At $11.00/shr (RTTNews)
06.05.24	EyePoint Stock Plunges 34% As Eye Treatment Fails To Meet Trial Goal (RTTNews)
04.03.24	EyePoint Pharma CMO Dario Paggiarino Quits, Ramiro Ribeiro Named Replacement (RTTNews)
05.02.24	Biotech High-Flyers That Just Hit 52-Week Highs (RTTNews)
04.12.23	EyePoint's Phase 2 DAVIO 2 Trial Of EYP-1901 Achieves Primary, Secondary Endpoints In Wet AMD (RTTNews)
10.08.23	These 11 Biotech Stocks Hit New Highs - Are They In Your Portfolio? (RTTNews)
10.07.23	EyePoint Pharma Appoints Jay Duker As CEO (RTTNews)
23.01.23	EyePoint To Build 40K Sq. Ft. Facility To Make EYP-1901, YUTIQ (RTTNews)
04.01.23	EyePoint COO Jay Duker Gets Additional Responsibility Of President (RTTNews)
01.08.22	EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Maintenance Treatment of Wet AMD (PR Newswire)
15.07.22	EyePoint: 12-month Data From DAVIO Trial Reinforces Safety, Efficacy For EYP-1901 (RTTNews)
15.07.22	EyePoint Pharmaceuticals Announces Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD (PR Newswire)
12.02.22	EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and Efficacy Data from Ongoing Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD (PR Newswire)
15.11.21	Pre-market Movers: CREX, BTB, EYPT, OXBR, MICT… (RTTNews)
13.11.21	EyePoint Reports Positive Interim Data From Phase 1 Trial Of EYP-1901 On Wet AMD Treatment (RTTNews)
13.11.21	EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD (PR Newswire)
04.01.21	Ocumension Therapeutics Invests $15.7 Mln In EyePoint Pharma (RTTNews)
27.10.20	ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz (RTTNews)
04.09.20	Pre-market Movers In Healthcare Sector: SONN, OBSV, OSUR, CVAC, OCGN... (RTTNews)
27.08.20	Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN... (RTTNews)
25.08.20	Pre-market Movers In Healthcare Sector: OCGN, CERS, IBIO, KMDA, SONN… (RTTNews)
24.08.20	Pre-market Movers In Healthcare Sector: SONN, ADMA, THMO, LMNL, KMDA... (RTTNews)
06.11.18	AKAO Hits New Low, INSY Shifts Focus From Opioids, FDA Nod For Theratechnologies (RTTNews)
15.10.18	EyePoint Pharma Gets FDA Approval Of YUTIQ; Stock Up (RTTNews)
26.09.18	AKCA Up 33% In 2 Days, AGTC Awaits XLRS Data, EYPT On Watch (RTTNews)
20.07.18	ACIU Back In Focus, MDXG Works To Undo Past Wrongs, AVEO To Report Data In Q4 (RTTNews)
26.04.18	EYPT Up 98% This Month, USNA In Good Health, MDXG To Report Q1 Results (RTTNews)
25.04.18	CHEK Explodes, ATOS Scripts History, CDMO Working On A Facelift, EYPT In Focus (RTTNews)
20.04.18	EBIO To Report Phase III Data In May, EYPT Catches Eyes, SIEN Gets FDA Nod (RTTNews)
13.04.18	MYND Excited, STDY Steadying Up, SELB Awaits Data In Q3, EYPT Catches Eyes (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’001.00	2.22 %	K V
Nestle	89.72	2.12 %	K V
Swisscom	519.50	1.56 %	K V
Novartis	100.92	1.46 %	K V
Roche Hldg G	307.00	1.42 %	K V
Logitech Intl	85.36	-0.97 %	K V
Sika	234.90	-1.43 %	K V
Alcon	80.54	-1.95 %	K V
Geberit	580.00	-2.09 %	K V
CieFinRichemont	164.85	-5.42 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu EyePoint Pharmaceuticals Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten